Skip to content
VB
Research Organization

Updated:

Virginia Biosciences Health Research Corporation

Virginia Biosciences Health Research Corporation (VBHRC), known as Virginia Catalyst, is a not-for-profit 501(c)(3) corporation funded by the Virginia...

Overview

Virginia Biosciences Health Research Corporation (VBHRC), known as Virginia Catalyst, is a not-for-profit 501(c)(3) corporation funded by the Virginia General Assembly’s general fund and seven of Virginia’s research universities. The organization has now awarded 24 grants totaling $10 million, combined with $20 million in matching funds, which financed the achievement of meaningful milestones. This then resulted in follow-on funding of an additional $80 million and the creation of high-paying jobs throughout the Commonwealth.

General information

Firm type

University-affiliated Translational Research Entity

Year founded

2012

Location

Region

North America

Country

United States

City

Virginia Beach

Corporate office

Virginia Beach, VA, United States

Principals

J. Paul Gilman

Chief Executive Officer

Jeffrey W. Sherman

Vice President, Clinical Research

Sector focus

Healthcare ServicesEducationLife SciencesInfrastructure

Frequently asked questions

How does VBHRC differ from a traditional venture capital firm investing in life sciences?

VBHRC is a nonprofit consortium formed by Virginia's research universities to manage translational research, rather than a for-profit VC. It provides gap funding and project management to de-risk academic discoveries, not direct equity investment. Its goal is to advance projects to a point where they attract commercial partners or follow-on investment from venture firms or pharmaceutical companies (per the firm's public description).

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Explore more profiles